Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CMS Defines Terms For Part D Protected Classes, Revises Multi-Step Review

Executive Summary

CMS' latest take on policy for "protected classes" under Medicare Part D identifies three key issues that will shape how such classes are chosen in the future: defining terms used in the statutory language, a new approach to the agency's previously proposed multi-step process for evaluating classes, and options for public comment on the agency's choices

You may also be interested in...

Medicare Part D Protected Classes Retained For 2011, With Exceptions Process, In Final CMS Rule

Medicare Part D formulary requirements for the six "protected" classes will be maintained through 2011 and until the agency establishes otherwise through rulemaking, under a final rule slated for April 15 publication.

CMS Opens Way To Add, Or Subtract, Protected Classes In Part D Formularies

CMS is creating a multi-step process that will give outside experts and the public a role in adding or subtracting "protected" drug classes in Medicare Part D, as well as making exceptions to the rule that all drugs must be covered in a protected class

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts